BMS ups investment in China
By Liu Jie | China Daily | Updated: 2011-07-15 07:56
Company says local partners, R&D will be instrumental to growth
BEIJING - China is expected to become the second- or third-largest market for international drugmaker Bristol-Myers Squibb's (BMS) within a decade.
The country is currently the eighth-largest market for the company and is expected to become the sixth-largest by next year.
Photo
